Brian Helfand
Division Head, Urology · Endeavor Health Cancer Institute
Credentials: · · · ·
History
- Present
Urology Division · Endeavor Health Cancer Institute
- Present
Prostate Cancer Department · Endeavor Health Cancer Institute
- Present
The University of Chicago Pritzker School of Medicine
2011–2012- 2001–2005
Research
A specific mechanism of nonspecific inhibition
Journal of Medicinal Chemistry · 2003 · 509 citations
Introducing intermediate filaments: from discovery to disease
Review · Journal of Clinical Investigation · 2009 · 347 citations
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Nature Genetics · 2008 · 310 citations
43 papers
- AG
34 papers · 2 as a resident
25 papers · 14 as a resident
22 papers · 20 as a resident
19 papers
18 papers
- CB
17 papers
17 papers
Grants
- 2012–2026
LURN II: Enhanced Characterization of Patients with LUTS Using Biopsychosocial Approaches
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $5.5M · University of Chicago
- 2002–2006
Ethanol Induced Changes in Intermed. Fliament Transport
National Institute on Alcohol Abuse and Alcoholism · F30
Contact PI · $166K · Northwestern University
Clinical trials
- 2024–2025
Principal investigator · Completed · Phase 4
Blue Earth Diagnostics
- 2025–2026
Site PI · Recruiting
Endeavor Health
- 2022–2039
MRI Screening in Men at High Risk of Developing Prostate Cancer
Site PI · Recruiting
University of Chicago